α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect
Por um escritor misterioso
Descrição
Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …
α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes
Arrhythmogenic Remodeling of β2 Versus β1 Adrenergic Signaling in the Human Failing Heart
Influence of pH on the uptake and toxicity of β-blockers in embryos of zebrafish, Danio rerio - ScienceDirect
Updates in the function and regulation of α1‐adrenoceptors - Akinaga - 2019 - British Journal of Pharmacology - Wiley Online Library
ANGPT2/CAV1 regulates albumin transcytosis of glomerular endothelial cells under high glucose exposure and is impaired by losartan
Labetalol - an overview
α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect
PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane
α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes
Targeting of G-protein coupled receptors in sepsis - ScienceDirect
In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect
Alpha-1-adrenergic receptors: Targets for agonist drugs to treat heart failure - Journal of Molecular and Cellular Cardiology
de
por adulto (o preço varia de acordo com o tamanho do grupo)
